These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35084654)

  • 21. mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis.
    Citraro R; Leo A; Constanti A; Russo E; De Sarro G
    Pharmacol Res; 2016 May; 107():333-343. PubMed ID: 27049136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seizure-induced microvascular injury is associated with impaired neurovascular coupling and blood-brain barrier dysfunction.
    Prager O; Kamintsky L; Hasam-Henderson LA; Schoknecht K; Wuntke V; Papageorgiou I; Swolinsky J; Muoio V; Bar-Klein G; Vazana U; Heinemann U; Friedman A; Kovács R
    Epilepsia; 2019 Feb; 60(2):322-336. PubMed ID: 30609012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in blood-brain barrier glucose transport in SIV-infected macaques.
    Mankowski JL; Queen SE; Kirstein LM; Spelman JP; Laterra J; Simpson IA; Adams RJ; Clements JE; Zink MC
    J Neurovirol; 1999 Dec; 5(6):695-702. PubMed ID: 10602410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GABAergic Interneuron and Neurotransmission Are mTOR-Dependently Disturbed in Experimental Focal Cortical Dysplasia.
    Zhong S; Zhao Z; Xie W; Cai Y; Zhang Y; Ding J; Wang X
    Mol Neurobiol; 2021 Jan; 58(1):156-169. PubMed ID: 32909150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicotine pre-exposure reduces stroke-induced glucose transporter-1 activity at the blood-brain barrier in mice.
    Shah KK; Boreddy PR; Abbruscato TJ
    Fluids Barriers CNS; 2015 Apr; 12():10. PubMed ID: 25925411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Underlying Cortical Dysplasia as Risk Factor for Traumatic Epilepsy: An Animal Study.
    Nemes A; Najm IM; Gale JT; Ying Z; Johnson M; Gonzalez-Martinez J
    J Neurotrauma; 2016 Oct; 33(20):1883-1891. PubMed ID: 26560499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GATORopathies: The role of amino acid regulatory gene mutations in epilepsy and cortical malformations.
    Iffland PH; Carson V; Bordey A; Crino PB
    Epilepsia; 2019 Nov; 60(11):2163-2173. PubMed ID: 31625153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypervascularization in mTOR-dependent focal and global cortical malformations displays differential rapamycin sensitivity.
    Zhang L; Huang T; Teaw S; Bordey A
    Epilepsia; 2019 Jun; 60(6):1255-1265. PubMed ID: 31125447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Balloon cells promote immune system activation in focal cortical dysplasia type 2b.
    Zimmer TS; Broekaart DWM; Luinenburg M; Mijnsbergen C; Anink JJ; Sim NS; Michailidou I; Jansen FE; van Rijen PC; Lee JH; François L; van Eyll J; Dedeurwaerdere S; van Vliet EA; Mühlebner A; Mills JD; Aronica E
    Neuropathol Appl Neurobiol; 2021 Oct; 47(6):826-839. PubMed ID: 34003514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment.
    Van Skike CE; Jahrling JB; Olson AB; Sayre NL; Hussong SA; Ungvari Z; Lechleiter JD; Galvan V
    Am J Physiol Heart Circ Physiol; 2018 Apr; 314(4):H693-H703. PubMed ID: 29351469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in electroencephalographic characteristics and blood-brain barrier permeability in WAG/Rij rats with cortical dysplasia.
    Sahin D; Yilmaz CU; Orhan N; Arican N; Kaya M; Gürses C; Ates N; Ahishali B
    Epilepsy Behav; 2017 Feb; 67():70-76. PubMed ID: 28088684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired oligodendroglial turnover is associated with myelin pathology in focal cortical dysplasia and tuberous sclerosis complex.
    Scholl T; Mühlebner A; Ricken G; Gruber V; Fabing A; Samueli S; Gröppel G; Dorfer C; Czech T; Hainfellner JA; Prabowo AS; Reinten RJ; Hoogendijk L; Anink JJ; Aronica E; Feucht M
    Brain Pathol; 2017 Nov; 27(6):770-780. PubMed ID: 27750396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood-brain barrier glucose transporter: effects of hypo- and hyperglycemia revisited.
    Simpson IA; Appel NM; Hokari M; Oki J; Holman GD; Maher F; Koehler-Stec EM; Vannucci SJ; Smith QR
    J Neurochem; 1999 Jan; 72(1):238-47. PubMed ID: 9886075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression.
    Buller CL; Loberg RD; Fan MH; Zhu Q; Park JL; Vesely E; Inoki K; Guan KL; Brosius FC
    Am J Physiol Cell Physiol; 2008 Sep; 295(3):C836-43. PubMed ID: 18650261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.
    Mirzaa GM; Campbell CD; Solovieff N; Goold C; Jansen LA; Menon S; Timms AE; Conti V; Biag JD; Adams C; Boyle EA; Collins S; Ishak G; Poliachik S; Girisha KM; Yeung KS; Chung BHY; Rahikkala E; Gunter SA; McDaniel SS; Macmurdo CF; Bernstein JA; Martin B; Leary R; Mahan S; Liu S; Weaver M; Doerschner M; Jhangiani S; Muzny DM; Boerwinkle E; Gibbs RA; Lupski JR; Shendure J; Saneto RP; Novotny EJ; Wilson CJ; Sellers WR; Morrissey M; Hevner RF; Ojemann JG; Guerrini R; Murphy LO; Winckler W; Dobyns WB
    JAMA Neurol; 2016 Jul; 73(7):836-845. PubMed ID: 27159400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood-brain barrier leakage after status epilepticus in rapamycin-treated rats I: Magnetic resonance imaging.
    van Vliet EA; Otte WM; Wadman WJ; Aronica E; Kooij G; de Vries HE; Dijkhuizen RM; Gorter JA
    Epilepsia; 2016 Jan; 57(1):59-69. PubMed ID: 26691904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain somatic mutations in MTOR leading to focal cortical dysplasia.
    Lim JS; Lee JH
    BMB Rep; 2016 Feb; 49(2):71-2. PubMed ID: 26779999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GLUT1 enhances mTOR activity independently of TSC2 and AMPK.
    Buller CL; Heilig CW; Brosius FC
    Am J Physiol Renal Physiol; 2011 Sep; 301(3):F588-96. PubMed ID: 21613414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-lasting blood-brain barrier dysfunction and neuroinflammation after traumatic brain injury.
    van Vliet EA; Ndode-Ekane XE; Lehto LJ; Gorter JA; Andrade P; Aronica E; Gröhn O; Pitkänen A
    Neurobiol Dis; 2020 Nov; 145():105080. PubMed ID: 32919030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy.
    Lim JS; Kim WI; Kang HC; Kim SH; Park AH; Park EK; Cho YW; Kim S; Kim HM; Kim JA; Kim J; Rhee H; Kang SG; Kim HD; Kim D; Kim DS; Lee JH
    Nat Med; 2015 Apr; 21(4):395-400. PubMed ID: 25799227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.